Nureca Ltd Share Price

Overview

Nureca Ltd share price is currently ₹329.67, up by ₹18.89 (6.08%) from its previous closing price of ₹310.78. The share price has gained 4% over the past month and gained 31.09% over the past year. The stock's 52-week low and high are ₹201.54 and ₹351.68, respectively. Nureca Ltd has a market capitalisation of ₹ 310.00 Cr. The share price was last updated on 09 Sep 2026, 12:44 PM IST.

Nureca Ltd
Nureca Ltd
NURECA
 0.00
 18.89
6.08%
Healthcare
 0.00(%)1D

Updated: 09 Sep 2026, 12:44:23 pm IST

Market Data

Open Price

 312.36

Prev. Close

 310.78
 312.36

Day Low

 329.67

Day High

 201.54

52 Week Low

 351.68

52 Week High

HealthcareMedical Equipment/Supplies/Accessories
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

78.68

Sector PE

42.03

PB Ratio

1.74

Sector PB

5.73

EPS

4.19

Dividend Yield

0.00

Today's Volume

11.236 K

5 Day Avg. Volume

5.505 K

PEG Ratio

0.50

Market Cap.

₹ 310.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Nureca Ltd 👋

Nureca Limited is a specialist in home healthcare and wellness products. Its products serve individuals, caregivers and medical practitioners across the globe. It offers a range of products specialized in home-based, non-invasive digital diagnosis and prevention of lifestyle diseases. Its range of products are spread across categories like respiratory wellbeing, physiotherapy, cardiac health monitoring, diabetes detection, mother and childcare and more. Its brands include Dr. Trust, trumom and Dr. Physio. Dr. Trust is a wellness and healthcare brand which provides medical devices and health monitoring solutions. trumom is a mother and childcare brand. Dr. Physio is an ortho and pain management brand. Its chronic devices include home monitoring devices and medical wearables that populate readings to identify health patterns. Its lifestyle products span weighing scales to yoga gear. Dr Trust 360 enables monitoring, analyses, storing and reporting of health data and patterns over time.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
RAJIV GUPTA (SEBI RA)

RAJIV GUPTA (SEBI RA)

20 Jun • 6:14 PM · SEBI-Registered Analyst

Launches Advanced Al Health Analytics - Nureca Ltd

Code BSE: 543264 NSE:

NURECA
Dr Trust 360 Crosses 2.4 Million Users ; Launches Advanced Al Health Analytics Nureca has also recently launched Dr Trust Intelligence, an Al-powered analytics suite within the Dr Trust 360 app. It moves beyond displaying raw readings by interpreting body-composition data in plain language, identifying meaningful trends and helping users understand whether their fitmess and nutrition efforts are moving in the right direction. The company believes this depth of Al-led body-composition interpretation is differentiated among home healthcare apps available in India.

See More
Dhwani Patel

Dhwani Patel

10 Jun • 3:31 PM · SEBI-Registered Analyst

RECLTD
- DOWNWARD CHANNEL

• REC remains trapped inside a well-defined downward channel, with every rally over the last year failing near the falling resistance trendline. • Support: ₹320–330 (recent swing zone) and channel support near ₹300. Resistance: ₹375–385 (channel resistance), followed by ₹420 if a breakout occurs. • The trend remains bearish-to-neutral until the stock closes above ₹385–390. A breakout from the channel could signal a trend reversal, while rejection near resistance would keep the broader downtrend intact.

RECLTD

See More
Pyrifera Investment Advisors

Pyrifera Investment Advisors

30 May • 1:01 AM · SEBI-Registered Analyst

Nureca Limited Approves ₹100 Cr Capex; Key Leadership Appointments

Nureca Limited's Board, in its meeting on May 29, 2026, approved several strategic decisions to strengthen operational capacity and governance: 1. Capital Expenditure: Approved incremental capex of up to ₹100 crore in plant and machinery to enhance production capabilities and support future growth initiatives. 2. Leadership Changes: Chander Kant Chief Financial Officer Appointed (ex-Manager Finance) June 27, 2026 Naresh Gupta CFO Resigned (better opportunities) June 26, 2026 Saurabh Goyal Managing Director Reappointed (3 years) Sept 3, 2026* Aryan Goyal Whole-time Director Reappointed (3 years) May 28, 2027* Smita Goyal Additional Director (WTD) Appointed (3 years) June 1, 2026* *Subject to shareholder approval at ensuing AGM 3. Governance: Reappointed M/s. MGSG and Associates as internal auditor for FY27 to ensure continued financial oversight and compliance. Strategic Context: The ₹100 Cr capex signals confidence in demand visibility for Nureca's healthcare brands (e.g., Equilibre, Dr. Morepen) and intent to scale manufacturing efficiency. Leadership continuity via reappointments of promoter directors, coupled with internal promotion of Chander Kant as CFO, ensures strategic alignment and operational stability during a growth phase. Outlook: With enhanced capacity and a reinforced leadership team, Nureca is positioned to execute its premiumization and category expansion strategy. Investor focus will shift to capex deployment timelines and margin trajectory post-investment.

NURECA

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

19 Jan • 7:54 AM · SEBI-Registered Analyst

Nureca Q3 FY26 – Strong Turnaround with Profitable Growth

Nureca delivered a powerful turnaround in the December 2025 quarter, registering healthy revenue growth and a decisive shift from losses to profitability, driven by improving operations and better cost efficiency. • Sales: ↑ 50% YoY to ₹39.6 crore (vs ₹26.5 crore in Dec 2024) • EBIDT: ↑ 181% YoY to ₹3.25 crore (vs -₹4.01 crore) • Net Profit: ↑ 233% YoY to ₹3.73 crore (vs -₹2.80 crore) • EPS: ↑ 240% YoY to ₹3.91 (vs -₹2.80) At a price of ₹312, market cap ₹298 crore, and PE 28.0, Nureca reflects a clear earnings revival after a challenging phase. The shift from losses to consistent profits highlights operational discipline and improving business traction, setting the foundation for sustained growth in the coming quarters.

See More
Shrikant Pandey

Shrikant Pandey

17 Jan • 9:20 PM · SEBI-Registered Analyst

NURECA

NURECA Q3 RESULTS Net Profit: ₹3.70 Cr 🟢 vs ₹2.80 Cr loss (YoY) | ⬆️ 3% QoQ Revenue: ₹39.60 Cr ⬆️ 50% YoY | ⬆️ 5% QoQ EBITDA: ₹3.27 Cr 🟢 vs ₹3.99 Cr loss (YoY) | ₹3.28 Cr profit QoQ EBITDA Margin: 8.25% ⬆️ vs -15.10% YoY | ⬇️ vs 8.70% QoQ

See More
Jeet B Bhayani (SEBI RA)

Jeet B Bhayani (SEBI RA)

30 Dec • 11:14 PM · SEBI-Registered Analyst

In a statement, the Indian government announced that 2025 experienced the largest annual boost in renewable energy capacity in the nation's history. This suggests that India is progressing toward cleaner, more sustainable energy sources. This remarkable growth was achieved through the collaborative actions of the Indian Government, major industry players, and state utility firms to enhance solar, wind, and other types of renewable energy nationwide. This accomplishment indicates that the overall wellness of India's renewable energy framework is improving, as new generation capacity is being efficiently implemented, leading to a more robust and reliable electricity supply while also reducing the carbon footprint per kilowatt-hour in the electric power industry. Multiple sources have indicated that the growth of renewable energy capacity in India has been driven by Utility-Scale Solar Commissioning and Wind Energy initiatives, along with the advancement of utility-scale grid integration for these renewable sources. These developments have been complemented by policies that promote private investment in renewable energy and efforts by private investors. The rise in renewable energy production capacity aligns with India's climate pledges and long-term energy goals, which include moving away from reliance on fossil fuels and embracing low-carbon technologies. Alongside a higher proportion of renewable energy in the overall energy mix, the expanding renewable energy capacity will lead to lower energy expenses, a broader range of energy supply sources, and chances to invest in new Renewable Energy infrastructure. The increase in Renewable Energy capacity in India showcases the considerable advancements the nation has achieved in building a robust Energy Economy and its role as a key participant in the global battle against Climate Change.

IREDA
RECLTD
INOXWIND
INOXGREEN
SUZLON
SWSOLAR

See More

Frequently Asked Questions

What is the share price of Nureca Ltd?

What is the market cap of Nureca Ltd?

Should I buy Nureca Ltd stock now?

What is the 52 week high and low of Nureca Ltd?

Is the Nureca Ltd stock good to buy?

Is Nureca Ltd a good buy for the long term?

Is Nureca Ltd overvalued or undervalued?

What is the PE and PB ratio of Nureca Ltd?

Start Now